CompletedPhase 3

Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)

NCT01614886

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novartis Investigative Site

Anjo, Aichi-ken, Japan

+49 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2012-07
Enrollment: 216 participants
Sponsor: Novartis Pharmaceuticals
Purpose: treatment

Locations (50)

Novartis Investigative SiteAnjo, Aichi-ken, Japan
Novartis Investigative SiteŌbu, Aichi-ken, Japan
Novartis Investigative SiteSeto, Aichi-ken, Japan
Novartis Investigative SiteToyoake, Aichi-ken, Japan
Novartis Investigative SiteAkita, Akita, Japan
Novartis Investigative SiteChiba, Chiba, Japan
Novartis Investigative SiteTōon, Ehime, Japan
Novartis Investigative SiteFukuoka, Fukuoka, Japan
Novartis Investigative SiteFujioka, Gunma, Japan
Novartis Investigative SiteHiroshima, Hiroshima, Japan
Novartis Investigative SiteMiyoshi, Hiroshima, Japan
Novartis Investigative SiteKasama, Ibaraki, Japan
Novartis Investigative SiteKamakura, Kanagawa, Japan
Novartis Investigative SiteKawasaki, Kanagawa, Japan
Novartis Investigative SiteKawasaki, Kanagawa, Japan
Novartis Investigative SiteSagamihara, Kanagawa, Japan
Novartis Investigative SiteYokohama, Kanagawa, Japan
Novartis Investigative SiteKochi, Kochi, Japan
Novartis Investigative SiteKochi, Kochi, Japan
Novartis Investigative SiteKōshi, Kumamoto, Japan
Novartis Investigative SiteKumamoto, Kumamoto, Japan
Novartis Investigative SiteKumamoto, Kumamoto, Japan
Novartis Investigative SiteKyoto, Kyoto, Japan
Novartis Investigative SiteKyoto, Kyoto, Japan
Novartis Investigative SiteKyoto, Kyoto, Japan
Novartis Investigative SiteSendai, Miyagi, Japan
Novartis Investigative SiteKitamorokata-gun, Miyazaki, Japan
Novartis Investigative SiteAzumino, Nagano, Japan
Novartis Investigative SiteMatsumoto, Nagano, Japan
Novartis Investigative SiteNagaoka, Niigata, Japan
Novartis Investigative SiteKurashiki, Okayama-ken, Japan
Novartis Investigative SiteOkayama, Okayama-ken, Japan
Novartis Investigative SiteSakai, Osaka, Japan
Novartis Investigative SiteSuita, Osaka, Japan
Novartis Investigative SiteSuita, Osaka, Japan
Novartis Investigative SiteKanzaki-gun, Saga-ken, Japan
Novartis Investigative SiteKasukabe, Saitama, Japan
Novartis Investigative SiteKawaguchi, Saitama, Japan
Novartis Investigative SiteKoshigaya, Saitama, Japan
Novartis Investigative SiteSaitama, Saitama, Japan
Novartis Investigative SiteShizuoka, Shizuoka, Japan
Novartis Investigative SiteShizuoka, Shizuoka, Japan
Novartis Investigative SiteTokushima, Tokushima, Japan
Novartis Investigative SiteBunkyo-ku, Tokyo, Japan
Novartis Investigative SiteHachiōji, Tokyo, Japan
Novartis Investigative SiteKoto-ku, Tokyo, Japan
Novartis Investigative SiteMusashino, Tokyo, Japan
Novartis Investigative SiteŌta-ku, Tokyo, Japan
Novartis Investigative SiteTachikawa, Tokyo, Japan
Novartis Investigative SiteShimonoseki, Yamaguchi, Japan